Scholars180 post-questionnaire raw data. gan Khyber Alam (13503163)

Pynciau:

List of eye conditions. gan Khyber Alam (13503163)

Pynciau:

Scholars180 pre-questionnaire raw data. gan Khyber Alam (13503163)

Pynciau:

Self-reported knowledge, attitudes, and knowledge application pre- and post-oral presentation (n = 31)^a. gan Khyber Alam (13503163)

Pynciau:

Demographic characteristics of test participants (n = 31). gan Khyber Alam (13503163)

Pynciau:

Peer evaluation of assignment organization (n = 31)^c. gan Khyber Alam (13503163)

Pynciau:

Cost-effectiveness acceptability curve for QALYs. gan Lotte Verweij (725951)

Pynciau:

Cost-effectiveness plane for QALYs comparing the intervention group to the usual care group. gan Lotte Verweij (725951)

Pynciau:

Cost-effectiveness plane for estimated readmission or mortality comparing the intervention group with the usual care group. gan Lotte Verweij (725951)

Pynciau:

Differences in readmission or mortality, QALYs and costs in €, ICERs, distribution of bootstrapped cost-effect pairs over the quadrants of the CE-plane, and the probability of cost... gan Lotte Verweij (725951)

Pynciau:

Cost-effectiveness acceptability curve for readmission or mortality. gan Lotte Verweij (725951)

Pynciau:

CCB intervention costs (€). gan Lotte Verweij (725951)

Pynciau:

Unadjusted mean costs (€) and effects over 6 months follow-up after multiple imputation. gan Lotte Verweij (725951)

Pynciau:

Baseline characteristics. gan Lotte Verweij (725951)

Pynciau:

Healthcare costs (€) used in the cost-effectiveness analysis. gan Lotte Verweij (725951)

Pynciau:

Flowchart. gan Lotte Verweij (725951)

Pynciau:

Sample organizational network with nodes colored by department. gan Thomas W. Valente (760722)

Pynciau:

Network with nodes colored by their groups based on a community detection algorithm. gan Thomas W. Valente (760722)

Pynciau:

Unadjusted primary outcome measures. gan Paula Elisabeth van Westrienen (15195132)

Pynciau:

Adjusted multivariate comparisons of primary and secondary outcome measures per group based on intention-to-treat analysis at 3 and 12 months. gan Paula Elisabeth van Westrienen (15195132)

Pynciau: